Since IFN-γ and TNF-α production by CD4+ T cells is hardly inhibited by Tregs in active sarcoidosis patients,12 we considered infliximab treatment as a chance for reducing inflammation, counteracting changes of immune cell frequencies and thereby ameliorating PML. The gene discussed is IFNG; the disease is sarcoidosis.